New Institute for Health Metrics and Evaluation estimates show global health financing dropped 5% in 2026, following a 12% cut in 2025, as the UK posted the largest absolute reduction and low-income countries face the largest shortfalls in their health budgets.

HEALTH SYSTEMS & DISEASE BURDEN · AID FINANCING · NOVEMBER 16, 2026 · GLOBAL
A 12% cut in 2025 left global health financing at its lowest level since 2012, and it fell further in 2026. New preliminary estimates published on October 20, 2026 by the Institute for Health Metrics and Evaluation (IHME), a research institute at the University of Washington in Seattle, show that financing for global health dropped a further 5% in 2026, following a 12% overall cut in 2025. The compounding effect is now translating from budget lines into service delivery, with low-income countries experiencing the largest shortfalls in their health budgets, according to IHME.
The largest absolute reduction in 2026 came from the United Kingdom, which cut its global health funding by 37%, or $891 million, according to IHME estimates. The United States recorded the next-largest absolute drop, reducing its development assistance for health by $668 million, or 8%, from 2025 levels. Canada and Germany each reduced contributions by more than $100 million — a 10% and 8% decline, respectively — per the same IHME estimates. IHME’s Resource Tracking research team is led by Joseph Dieleman, a professor of health metrics sciences at the University of Washington.
$5.8B
KFF (formerly the Kaiser Family Foundation) estimates the cumulative cut to US and Global Fund funding in 29 countries with US global health memoranda of understanding (MOUs), including unexpected 2026 reductions, reached $5.8 billion.
Multilateral Retreat and the Partial Offset
The retreat extended to multilateral agencies. IHME estimates show an 18% decline — equivalent to $873 million — in annual disbursements from United Nations agencies between 2025 and 2026, and a 15% drop, or $447 million, from Gavi, the Vaccine Alliance. Both organizations have drawn on short-term reserves to buffer steeper immediate cuts, though IHME notes that their long-term financial outlook remains uncertain.
A partial offset came from a small set of actors moving against the trend. IHME estimates that Japan grew its contributions by 2%, or $32 million, a move the IHME authors attribute to Japan’s broader foreign policy agenda of elevating global health as an instrument of diplomacy and consolidating its standing with the Global South. The Bill and Melinda Gates Foundation increased its contributions by an estimated 4%, or $249 million, from 2025 to 2026; IHME estimates place the Gates Foundation as the second-largest single source of development assistance for health in 2026, behind only the United States. Regional development banks — including the African Development Bank, the Asian Development Bank, and the Inter-American Development Bank — collectively increased development assistance for health by an estimated 32%, or $270 million, over the same period, with IHME’s data suggesting the focus of that increase is health systems strengthening. The World Bank raised its funding by an estimated 2%, or $91 million.
These increases are real but arithmetically insufficient: the four gains IHME reports (Japan, Gates, regional banks, World Bank) total $642 million, against $1,559 million cut by the UK and US alone. A 32% rise from regional development banks and a 4% rise from the Gates Foundation do not offset an $891 million cut from the UK and a $668 million cut from the US in the same year, on IHME’s own figures.
Low-Income Countries and the Domestic Spending Gap
Among low-income countries, total health spending per person — including donor funding — is estimated to have dropped by an average of 3% per year between 2024 and 2026, according to IHME, even as government health spending per person grew by an average of 8% per year over the same period. The gap between those two trajectories illustrates the scale of donor dependence: domestic governments are increasing effort, but the donor withdrawal is larger in absolute terms for the most aid-reliant economies. Sub-Saharan Africa, which has historically received the largest share of development assistance for health, has experienced the largest regional reduction in global health funding, per IHME.
Middle-income countries have been less exposed. IHME estimates that total health spending grew among lower-middle-income countries by an average of 1% per year between 2024 and 2026, and by 3% among upper-middle-income countries, despite declining development assistance.
A separate survey published on September 6, 2026 by the Partnership for Maternal, Newborn and Child Health (PMNCH), a World Health Organization-hosted alliance, found that 69% of its partner organizations across 67 countries had already downsized, temporarily suspended, or permanently closed programs. The Organisation for Economic Co-operation and Development (OECD) projects that official development assistance will fall by a further 6.9% in 2026, marking a third consecutive year of decline, according to OECD projections published in June 2026. The OECD projects health aid to fall by 29% to 46% between 2024 and 2026, to its lowest level in almost two decades. Population and reproductive health faces the largest cut by volume (a projected 54.1% decline), while malaria and tuberculosis control face the steepest percentage declines (59.6% and 57.2%).
A separate analysis by KFF, a US health-policy research organization, published on June 10, 2026 — co-authored by Jennifer Kates, Stephanie Oum, and Adam Wexler — assessed the combined impact of US and Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) reductions in 29 countries that have signed or signaled intent to sign MOUs with the US government under its America First Global Health Strategy. That analysis estimates a combined decline of $4.3 billion, a 24% drop relative to prior funding levels, between 2026 and 2029, with 77% of the reduction driven by the US. The cumulative cut, accounting for unexpected reductions in 2026, reached an estimated $5.8 billion, according to KFF.
The structural response from recipient countries has taken two forms. Forty-nine of 54 African countries have raised health spending, according to IHME, but the increases have not been sufficient to offset donor losses. A second response is political: African countries, led by Ghana’s President John Dramani Mahama, developed the Accra Reset, an initiative that pledges to center sovereignty and Global South voices in global health governance, including strengthening national health systems and local pharmaceutical manufacturing. IHME’s own analysis notes, however, that enough new domestic money has yet to materialize to cover existing health needs — a gap between political commitment and fiscal capacity that defines the near-term outlook.
For pharmaceutical companies and non-governmental organizations whose procurement volumes in low-income markets depend on donor-funded programs, the contraction may be associated with a structural reduction in addressable demand for vaccines and essential medicines. The PMNCH survey of partner organizations based in 67 countries found that nearly 80% of partner organizations faced reduced or uncertain funding as of September 2026, with 77% reporting that global disruptions were having a moderate, significant, or severe impact on their ability to advance women’s, children’s, and adolescents’ health programs — a concrete operational signal for any supplier whose order book includes donor-intermediated procurement.
What to Watch
- Whether Congress sets final US Fiscal Year 2027 global health funding before the stopgap continuing resolution expires on December 11, 2026: the administration requested $5.1 billion for the Global Health Programs account, $4.3 billion below the FY 2026 level of $9.4 billion, per KFF, while the House-passed bill provides $8.88 billion, $532 million below FY 2026
- Whether the Accra Reset translates into measurable increases in domestic health budgets among African signatory countries, as IHME’s current estimates suggest the gap between intent and fiscal reality remains wide
- The pace at which regional development banks scale health systems strengthening commitments, given their estimated 32% ($270 million) increase in 2026, per IHME
Global Health Funding Decline · IHME Preliminary Estimates, October 20, 2026
| Indicator | 2025 | 2026 |
|---|---|---|
| Global health funding decline | 12% | 5% |
| UN agencies disbursement decline | 18% / $873 million (2025–2026) | |
| Gavi disbursement decline | 15% / $447 million (2025–2026) | |
| UK absolute cut | $891 million / 37% (2026) | |
| US development assistance for health cut | $668 million / 8% (2026) | |
| Gates Foundation contribution increase | 4% / $249 million (2025–2026) | |
| Regional development banks increase | 32% / $270 million (2025–2026) | |
Source: IHME preliminary estimates via Think Global Health, 20 October 2026
Why this is relevant
Patients
IHME estimates total health spending per person in low-income countries fell an average of 3% per year between 2024 and 2026, even as domestic government spending grew 8% annually, suggesting donor withdrawal is outpacing the fiscal capacity of the most aid-dependent health systems to compensate.
Industry
Pharmaceutical companies and non-governmental organizations whose order books include donor-intermediated procurement may face reduced addressable demand; the PMNCH survey found 69% of partner organizations across 67 countries had already downsized, suspended, or closed programs as of September 2026.
Payers
Governments in low-income countries are being asked to absorb shortfalls that domestic budgets cannot fully cover; the Accra Reset initiative signals political intent to redirect resources toward health, but IHME notes that enough new domestic money has yet to materialize to cover existing needs.
Regulators
The US administration’s FY 2027 budget request proposes a Global Health Programs account of $5.1 billion, $4.3 billion below the FY 2026 amount of $9.4 billion, per KFF analysis; the House-passed bill instead provides $8.88 billion, $532 million below FY 2026, and final FY 2027 levels remain unresolved under a continuing resolution running to December 11, 2026.
Sources: Think Global Health: The State of Global Health Funding: October 2026 · PMNCH/WHO: Global Funding Crisis Deepens as 7 in 10 PMNCH Partners Report Program Cuts, Suspensions or Closures · KFF: Analysis of U.S. and Global Fund Funding Reductions in MOU Countries · KFF: Global Health Funding in the FY 2027 President’s Budget Request · OECD: The latest 2026 ODA projections reveal aid for health is further at risk · OECD: ODA projections for 2026 and the near term · IHME: Joseph Dieleman · House Appropriations Committee: FY27 National Security, Department of State, and Related Programs bill summary · Congressional Research Service: Overview of Continuing Appropriations for FY2027 · Congressional Research Service: R48956
Related
THE HEALTHSIGNALS BRIEF
A fortnightly PDF compiling our analysis on pharma, medical devices, health policy and epidemiology across Latin America and the United States.
Built for pharma, market-access, regulatory, policy and investor teams, with the main findings of our gated reports included.




